Fusen Pharmaceutical (01652.HK): "Valsartan Potassium Tablets" received approval for market launch.

Wisdom Financial News APP, Fosun Pharma (01652.HK) announced that its wholly-owned subsidiary, Jiaheng (Zhuhai Hengqin) Medical Technology Co., Ltd., has developed the "Valsartan Potassium Tablets" (trademark: Quainoping). The application for listing has been approved by the China National Medical Products Administration for the treatment of primary hypertension.